Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Cytori Therapeutics
3215
Cytori Therapeutics
Health Care
Medical
Technology
Biotechnology
Developing cell therapies for significant medical conditions including hand scleroderma, knee osteoarthritis, thermal burns and stress urinary incontinence.
Suggest edits
Founded
1996
Raised
$67.6M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
Dan
Edge
GoFundMe
Industry
Illumina
TuSimple
Bandsintown
Satechi
Companies in the same industry
Myomo
GrowBLOX Sciences
Esperion Therapeutics
Amplyx Pharmaceuticals, Inc
Perez Forensic Strategies
PeptiMimesis
Connect Biopharmaceuticals
ins2outs
Aalto University School of Science and Technology
Vytrus Biotech
Alexa global traffic share
Twitter followers
Overview
Funding
4
Acquisitions
1
Add info
Latest funding
Show all
$17,100,000
Post-IPO equity - 2016
$13,500,000
Post-IPO equity - 2014
Team Size
50+
Employees
I work here
Location
San Diego
,
United States
Headquarters
Explore San Diego
Acquisition
Xconomy
Cytori Buys San Antonio-based Azaya’s Drug Delivery Tech for Stock
Health
$17,100,000
Post-IPO equity
businesswire
,
MassDevice
Cytori Closes Rights Offering for Gross Proceeds of $17.1 Million | Business Wire